Understand the source comparison
Sermorelin Gene Expression: Peptide Therapy Comparison
Here's how sermorelin compares to other peptide-based approaches that influence growth hormone pathways: Sermorelin Direct GHRH receptor agonist. Activates GH1 gene transcription in pituitary somatotrophs 90–120 minutes post-injection GHRH receptor (class B GP
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Here's how sermorelin compares to other peptide-based approaches that influence growth hormone pathways:
- Sermorelin
- Direct GHRH receptor agonist. Activates GH1 gene transcription in pituitary somatotrophs
- 90–120 minutes post-injection
- GHRH receptor (class B GPCR)
- Yes. Amplifies endogenous pulse
- Gold standard for GH axis stimulation without axis suppression. Preserves feedback loops
- GHRP-2
- Ghrelin receptor agonist. Stimulates GH release and modest GH gene transcription
- 30–60 minutes post-injection
- Ghrelin receptor (GHS-R1a)
- Yes. Synergistic with endogenous GHRH
- Faster onset than sermorelin but less transcriptional depth. Best used in combination protocols
- Ipamorelin
- Selective ghrelin receptor agonist. GH release without cortisol or prolactin elevation
- 45–90 minutes post-injection
- Yes. Minimal hypothalamic disruption
- Cleanest ghrelin mimetic available. No cortisol spike, making it ideal for evening dosing
- CJC-1295 (DAC)
- Long-acting GHRH analogue. Extends plasma half-life to 6–8 days
- Sustained elevation over 7–10 days
- No. Creates tonic elevation
- Loss of pulsatility is a significant downside. Chronic elevation increases insulin resistance risk
- MK-677 (Ibutamoren)
- Oral ghrelin receptor agonist. Stimulates GH and IGF-1 without injection
- 60–120 minutes post-dose (oral)
- Partially. Blunted amplitude vs injected peptides
- Convenience of oral dosing but lower peak amplitude and increased appetite as side effect
- Sermorelin remains the most direct method for activating sermorelin gene expression without disrupting the hypothalamic-pituitary feedback system. Ghrelin mimetics like GHRP-2 and ipamorelin work through a parallel pathway and are often stacked with sermorelin to amplify the transcriptional effect.